Potential surrogate endpoints for overall survival (OS) in immunotherapy (IO)-treated metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study

被引：0
|
作者：
Saliby, R. M. [1 ]
Xie, W. [2 ]
Wells, J. C. [3 ]
Saad, E. [1 ]
Eid, M. [1 ]
Semaan, K. [1 ]
Labaki, C. [4 ]
Ferrier, E. [5 ]
Zarba, M. [5 ]
Ebrahimi, H. [6 ]
Suarez Rodriguez, C. [7 ]
Ruiz, J. M. [8 ]
Powles, T. B. [9 ]
Wood, L. A. [10 ]
De Velasco Oria, G. A. [11 ]
Takemura, K. [12 ]
Braun, D. A. [13 ]
Heng, D. Y. C. [14 ]
Choueiri, T. K. [1 ]
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA
[3] BC Canc Agcy, Med Oncol, Vancouver, BC, Canada
[4] Dana Farber Canc Inst, Med Genet Unit, Boston, MA 02115 USA
[5] Tom Baker Canc Clin, Med Oncol, Calgary, AB, Canada
[6] City Hope Comprehens Canc Ctr, Med Oncol, Duarte, CA USA
[7] Vall dHebron Univ Hosp, Oncol Dept, Barcelona, Spain
[8] Ipsen Mexico S RL CV, Med Oncol, Mexico City, DF, Mexico
[9] Barts Hlth NHS Trust, St Bartholomews Hosp, Oncol Dept, London, England
[10] Dalhousie Univ, Div Med Oncol, Dept Med, Halifax, NS, Canada
[11] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
[12] JFCR, Canc Inst Hosp, Genitourinary Oncol, Koto Ku, Tokyo, Japan
[13] Yale Univ, Sch Med, Yale Canc Ctr, Ctr Mol & Cellular Oncol, New Haven, CT USA
[14] Tom Baker Canc Clin, Oncol Dept, Calgary, AB, Canada
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1797
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1704P
引用
收藏
页码：S1021 / S1022
页数：2
相关论文
共 50 条
  • [31] Impact of smoking status (SS) on the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with first line (1L) immuno-oncology (IO)-combination regimens: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Gebrael, Georges
    Saad, Eddy
    Labaki, Chris
    Saliby, Renee Maria
    Sayegh, Nicolas
    Wells, J. Connor
    Semaan, Karl
    Eid, Marc
    Takemura, Kosuke
    Ernst, Matthew Scott
    Lemelin, Audreylie
    Basappa, Naveen S.
    Wood, Lori
    Powles, Thomas
    Ernst, D. Scott
    Kapoor, Anil
    Xie, Wanling
    Agarwal, Neeraj
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Impact of bone and liver metastases (BM, LM) in patients with metastatic renal cell carcinoma (mRCC) treated with molecularly targeted agents (MTAs): Results from the International mRCC Database Consortium (IMDC)
    McKay, Rana R.
    Kroeger, Nils
    Xie, Wanling
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Bjarnason, Georg A.
    MacKenzie, Mary J.
    Wood, Lori
    Srinivas, Sandy
    Vaishampayan, Ulka N.
    Rha, Sun Young
    Pal, Sumanta Kumar
    Donskov, Frede
    Tantravahi, Srinivas
    Rini, Brian I.
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [33] Outcome of metastatic sarcomatoid renal cell carcinoma (sRCC): Results from the International mRCC Database Consortium
    Chittoria, Namita
    Zhu, Hui
    Choueiri, Toni K.
    Kroeger, Nils
    Lee, Jae-Lyun
    Srinivas, Sandy
    Knox, Jennifer
    Bjarnason, Georg A.
    MacKenzie, Mary J.
    Wood, Lori
    Vaishamayan, Ulka N.
    Agarwal, Neeraj
    Pal, Sumanta Kumar
    Tan, Min-Han
    Rha, Sun Young
    Yuasa, Takeshi
    Donskov, Frede
    North, Scott A.
    Rini, Brian I.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) - a validation study
    Pond, G. R.
    Dietrich, M.
    Gruenwald, V.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] First-, second-, third-line therapy for metastatic renal cell carcinoma (mRCC): Benchmarks for trials design from the International mRCC Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Rini, Brian I.
    Lee, Jae-Lyun
    Kroeger, Nils
    Srinivas, Sandy
    Harshman, Lauren Christine
    Knox, Jennifer J.
    Bjarnason, Georg A.
    MacKenzie, Mary J.
    Wood, Lori
    Vaishampayan, Ulka N.
    Agarwal, Neeraj
    Pal, Sumanta Kumar
    Tan, Min-Han
    Rha, Sun Young
    Yuasa, Takeshi
    Donskov, Frede
    Bamias, Aristotelis
    North, Scott A.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Second-line VEGF TKI after IO combination therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
    Stukalin, Igor
    Dudani, Shaan
    Wells, Connor
    Gan, Chun Loo
    Pal, Sumanta K.
    Dizman, Nazli
    Powles, Thomas
    Donskov, Frede
    Wood, Lori
    Bakouny, Ziad
    Kollmannsberger, Christian K.
    Basappa, Naveen S.
    Hansen, Aaron Richard
    de Velasco, Guillermo
    Beuselinck, Benoit
    Canil, Christina M.
    Vaishampayan, Ulka N.
    Agarwal, Neeraj
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [37] Outcomes with durvalumab and savolitinib in metastatic papillary renal cancer (mPRC) according to international metastatic renal cell carcinoma database consortium (IMDC) risk groups
    Choy, J.
    Suarez Rodriguez, C.
    Larkin, J.
    Patel, P.
    Perez Valderrama, B.
    Rodriguez-Vida, A.
    Glen, H.
    Thistlethwaite, F.
    Ralph, C.
    Srinivasan, G.
    Mendez Vidal, M. J.
    Carter, A.
    Tyson, C.
    Prendergast, A.
    Mousa, K.
    Powles, T. B.
    Szabados, B. E.
    ANNALS OF ONCOLOGY, 2020, 31 : S1446 - S1446
  • [38] Outcomes of patients with brain metastases from renal cell carcinoma treated with firstline therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Takemura, Kosuke
    Lemelin, Audreylie
    Ernst, Matthew Scott
    Wells, Connor
    Basappa, Naveen S.
    Szabados, Bernadett
    Powles, Thomas
    Davis, Ian D.
    Wood, Lori
    Kapoor, Anil
    Mckay, Rana R.
    Lee, Jae-Lyun
    Meza, Luis A.
    Pal, Sumanta Monty
    Donskov, Frede
    Yuasa, Takeshi
    Gebrael, Benoit Beuselinck Georges
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [39] First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An analysis from the International mRCC Database Consortium
    Harshman, Lauren Christine
    Wood, Lori
    Srinivas, Sandy
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [40] Association between biopsychosocial distress (BPSD) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Bergerot, C. D.
    Clark, K. L.
    Ashing, K. T.
    Almeida, L.
    Bergerot, P. G.
    Obenchain, R.
    Dizman, N.
    Hsu, J.
    Maia, M. C.
    Philip, E.
    Loscalzo, M.
    Pal, S. K.
    ANNALS OF ONCOLOGY, 2017, 28
12345